Literature DB >> 8485431

Recycling with nicotine patches in smoking cessation.

P Tønnesen1, J Nørregaard, U Säwe, K Simonsen.   

Abstract

The aim was to evaluate if recycling of failures from a smoking cessation study may be of value. The study comprised 126 smokers (50%) of 252 failures, from a double-blind smoking cessation trial with nicotine patch, who accepted recycling after 1 year. Subjects were allocated nicotine patches delivering 15, 20 or 25 mg of nicotine (over 16 hours) according to their base-line saliva cotinine concentrations in an open trial. The treatment period was 12 weeks followed by tapering over 6 weeks. The percentage of quitters after 3, 12, 26, and 52 weeks was 44, 20, 7 and 6%, respectively. After 26 weeks, all subjects had relapsed in the group previously treated with active nicotine patch compared with 12% abstainers in the previous placebo subjects. The sustained abstinence rate without slips after one year was 2%. Recycling does not seem to be of long-term clinical relevance in our set-up for subjects initially treated with nicotine, but of some value in subjects quitting without nicotine therapy initially.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8485431     DOI: 10.1111/j.1360-0443.1993.tb02060.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  14 in total

1.  Double blind trial of repeated treatment with transdermal nicotine for relapsed smokers.

Authors:  S G Gourlay; A Forbes; T Marriner; D Pethica; J J McNeil
Journal:  BMJ       Date:  1995-08-05

2.  Predictors of early versus late smoking abstinence within a 24-month disease management program.

Authors:  Lisa Sanderson Cox; Jo A Wick; Niaman Nazir; A Paula Cupertino; Laura M Mussulman; Jasjit S Ahluwalia; Edward F Ellerbeck
Journal:  Nicotine Tob Res       Date:  2011-01-13       Impact factor: 4.244

Review 3.  Interventions to address chronic disease and HIV: strategies to promote smoking cessation among HIV-infected individuals.

Authors:  Raymond Niaura; Geetanjali Chander; Heidi Hutton; Cassandra Stanton
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

4.  Effectiveness of Switching Smoking-Cessation Medications Following Relapse.

Authors:  Bryan W Heckman; K Michael Cummings; Karin A Kasza; Ron Borland; Jessica L Burris; Geoffrey T Fong; Ann McNeill; Matthew J Carpenter
Journal:  Am J Prev Med       Date:  2017-03-20       Impact factor: 5.043

5.  Chronic disease management for tobacco dependence: a randomized, controlled trial.

Authors:  Anne M Joseph; Steven S Fu; Bruce Lindgren; Alexander J Rothman; Molly Kodl; Harry Lando; Brandon Doyle; Dorothy Hatsukami
Journal:  Arch Intern Med       Date:  2011-11-28

Review 6.  Clinical efficacy of bupropion in the management of smoking cessation.

Authors:  Douglas Jorenby
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

Authors: 
Journal:  Am J Prev Med       Date:  2008-08       Impact factor: 5.043

8.  Telephone-based tobacco-cessation treatment: re-enrollment among diverse groups.

Authors:  Beatriz H Carlini; Susan M Zbikowski; Harold S Javitz; T Mona Deprey; Sharon E Cummins; Shu-Hong Zhu
Journal:  Am J Prev Med       Date:  2008-07       Impact factor: 5.043

9.  Effect of varying levels of disease management on smoking cessation: a randomized trial.

Authors:  Edward F Ellerbeck; Jonathan D Mahnken; A Paula Cupertino; Lisa Sanderson Cox; K Allen Greiner; Laura M Mussulman; Niaman Nazir; Theresa I Shireman; Kenneth Resnicow; Jasjit S Ahluwalia
Journal:  Ann Intern Med       Date:  2009-04-07       Impact factor: 25.391

Review 10.  Tobacco addiction.

Authors:  Dorothy K Hatsukami; Lindsay F Stead; Prakash C Gupta
Journal:  Lancet       Date:  2008-06-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.